Maca Menopause RCT: Sexual Function and Mood Improved Without Hormonal Effect
WELLNESS

Maca Menopause RCT: Sexual Function and Mood Improved Without Hormonal Effect

By Anya · · https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1360422/full
KO | EN

The mechanism of Peruvian Andean highland plant maca (Lepidium meyenii) is becoming clearer. Frontiers in Pharmacology 2024 comprehensive review confirmed it improves menopausal sexual function and mood via non-hormone-mediated pathway (endocannabinoid + HPA-serotonin).

Mechanism core results

No hormone effect: Brooks 2008 (Menopause journal) postmenopausal women n=14, 3.5 g/day 6 weeks. No change in estradiol, FSH, LH, SHBG, testosterone.

Anxiety/depression reduction: Same trial HAM-D score reduced meaningfully.

SSRI-induced sexual dysfunction: Dording trial n=20 (17 women, 3 men). 3.0 g/day 12 weeks improved ASEX and MGH-SFQ meaningfully. 1.5 g/day weak. Dose-dependent.

Menopausal hot flashes and night sweats: Meissner trial 2 g/day gelatinized maca 3 months. Greene Climacteric Score reduced.

Libido (men): Gonzales 2002 healthy adult men 1.5~3 g/day 12 weeks. Libido improved at 8 weeks. No testosterone change.

What is maca

Maca (Lepidium meyenii): Cruciferous plant from Peruvian Andean highlands (3,500~4,500 m). Edible/medicinal root.

Dietary use: Used by Peruvian natives 2,000 years. Nutrition + vitality + reproductive support.

Color classification: Yellow (60% of total), red (20~25%), black (15~20%).

Gelatinized vs raw: Gelatinized via heat treatment removes starch. Absorption advantage.

Active compounds: Macamides, macaenes, glucosinolates, sterols.

Mechanism

Macamides (FAAH inhibition): Non-polar N-benzylalkamides. FAAH (fatty acid amide hydrolase) inhibition → anandamide (endocannabinoid) increase. Sexual function, neuroprotection, anti-inflammatory.

HPA-serotonin pathway: Hypothalamic-pituitary-adrenal axis modulation. 5-HT generation. Mood improvement.

Non-hormone-mediated: No estrogen mimicry. Hormone-dependent tumor concern weak.

Macaenes: Unsaturated fatty acids. Lipid metabolism + fatty acid oxidation modulation.

Glucosinolates: Antioxidant. Free radical scavenging.

Color-specific effects

Black maca: Male sperm production + epididymal motility (42d). Vitality.

Red maca: Most effective for female sexual function. Postmenopausal bone loss prevention. Prostate weight reduction.

Yellow maca: General reproductive support. Most commonly used in trials.

Most trials use unspecified or yellow. Color comparison trials limited.

Effect matrix

Hot flashes/night sweats: 2 g/day gelatinized - Greene Score reduction.

Libido (men): 1.5~3 g/day - improved at 8 weeks.

Sexual dysfunction (SSRI): 3.0 g/day meaningful. 1.5 g/day weak.

Mood (anxiety/depression): 3.5 g/day - HAM-D reduction.

Orgasm (postmenopausal): Meaningfully improved vs placebo.

Arousal (perimenopausal): Improved.

Hormone effect: None (non-hormonal mechanism).

Who fits

Perimenopause/postmenopause hot flashes + mood: Non-hormone-mediated option. Physician evaluation.

SSRI-induced sexual dysfunction: Adjunct option when drug change difficult.

Hormone concern patients: Breast cancer family history, uterine fibroids etc. hormone-dependent concerns: non-hormonal option.

Male libido decline: 1.5~3 g/day without hormone effect.

Menopause climacteric matrix: Maca + other adjuncts combined.

Who should be careful

Maca allergy: Caution with cruciferous (mustard, kale) allergies.

Thyroid function: Cruciferous can have thyroid effects. Thyroid patients consult physician.

Hormone-dependent tumors (theoretical): Non-hormonal mechanism but caution. Consult physician.

Drug interactions: Caution with anticoagulants like warfarin (vitamin K content). Time-separate.

Pregnancy/breastfeeding: Limited data. Consult physician.

GI sensitivity: 3 g/day 12 weeks reported some GI discomfort, headache, irritability.

Rare reports: 1 vaginal bleeding case (24F), 1 manic episode case (27M, no psych history). 2024 ACG drug-induced liver injury case report.

Dose and forms

Gelatinized menopause hot flashes: 2 g/day 3 months.

SSRI-induced sexual function: 3 g/day 12 weeks.

Postmenopause mood: 3.5 g/day 6 weeks.

Male libido: 1.5~3 g/day 12 weeks.

Duration: Effect assessment at 4~12 weeks.

Other menopause adjuncts

Black cohosh: Some hot flash data.

Isoflavones (soy): Weak estrogenic action.

Vitex (chasteberry): Prolactin modulation.

DHEA: Adrenal hormone adjunct.

Omega-3: Mood, joints.

Maca + Vitex + DHEA matrix option.

Daily guide

Step 1 - Assessment: Physician evaluation. Confirm menopause stage, symptoms, medications.

Step 2 - Dietary foundation: Nutrition balance, exercise, sleep.

Step 3 - Supplement start: Gelatinized maca 2~3 g/day.

Step 4 - 4~12 week assessment: Hot flashes, mood, sexual function changes.

Step 5 - Color adjustment: Women: red, men: black option.

Step 6 - Monitoring: Thyroid function, liver enzymes (rare reports), drug interactions.

Maca is a non-hormone-mediated menopause adjunct. FAAH inhibition + HPA-serotonin pathway. Adjunct on the foundation. Physician evaluation and monitoring essential.